Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-25-000572
Filing Date
2025-02-13
Accepted
2025-02-13 13:20:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5175
  Complete submission text file 0000930413-25-000572.txt   7119
Mailing Address 30 HUDSON STREET JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET JERSEY CITY NJ 07302 201-827-2000
LORD, ABBETT & CO. LLC (Filed by) CIK: 0000728100 (see all company filings)

EIN.: 135620131 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Subject) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92778 | Film No.: 25618903
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)